KENNETH R HESS to Enzyme Inhibitors
This is a "connection" page, showing publications KENNETH R HESS has written about Enzyme Inhibitors.
Connection Strength
0.170
-
Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design. J Clin Oncol. 2001 Aug 01; 19(15):3445-6.
Score: 0.117
-
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas. Neuro Oncol. 2004 Jan; 6(1):28-32.
Score: 0.035
-
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. J Neurooncol. 2006 Oct; 80(1):83-90.
Score: 0.010
-
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol. 2002 Mar 01; 20(5):1383-8.
Score: 0.008